The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

The nation’s two largest Medicare Advantage (MA) insurers say they support reforming the federal program to rein in certain ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

Humana has proposed limiting how Medicare Advantage insurance companies can bill the federal government for some diagnoses.

DURHAM, N.C. (WTVD) -- The Anaplastology Clinic in Durham doesn't offer typical medical services. Instead, it helps patients ...

Humana beat first-quarter profit and sales estimates as it reduced costs and exited some Medicare Advantage plans.

After taking silver in dramatic fashion at Paris 2024, Canadian beach volleyball duo Melissa Humana-Paredes and Brandie ...

Humana is a private insurer that offers Part D prescription drug coverage with some of its Medicare Advantage plans. The company also offers three stand-alone Part D options. Medicare Part D ...

Shares of Humana Inc. were headed higher in early Wednesday trading, after the health insurer reported first-quarter earnings that rose well above expectations, as costs declined and the exit from ...

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...